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Abstract
Virtually all of the elements of Mycobacterium tuberculosis (Mtb) pathogenesis, including pro-inflammatory cytokine
production, granuloma formation, cachexia, and mortality, can be induced by its predominant cell wall glycolipid, trehalose
6,69-dimycolate (TDM/cord factor). TDM mediates these potent inflammatory responses via interactions with macrophages
both in vitro and in vivo in a myeloid differentiation factor 88 (MyD88)-dependent manner via phosphorylation of the
mitogen activated protein kinases (MAPKs), implying involvement of toll-like receptors (TLRs). However, specific TLRs or
binding receptors for TDM have yet to be identified. Herein, we demonstrate that the macrophage receptor with
collagenous structure (MARCO), a class A scavenger receptor, is utilized preferentially to ‘‘tether’’ TDM to the macrophage
and to activate the TLR2 signaling pathway. TDM-induced signaling, as measured by a nuclear factor-kappa B (NF-kB)-
luciferase reporter assay, required MARCO in addition to TLR2 and CD14. MARCO was used preferentially over the highly
homologous scavenger receptor class A (SRA), which required TLR2 and TLR4, as well as their respective accessory
molecules, in order for a slight increase in NF-kB signaling to occur. Consistent with these observations, macrophages from
MARCO
2/2 or MARCO
2/2SRA
2/2 mice are defective in activation of extracellular signal-related kinase 1/2 (ERK1/2) and
subsequent pro-inflammatory cytokine production in response to TDM. These results show that MARCO-expressing
macrophages secrete pro-inflammatory cytokines in response to TDM by cooperation between MARCO and TLR2/CD14,
whereas other macrophage subtypes (e.g. bone marrow–derived) may rely somewhat less effectively on SRA, TLR2/CD14,
and TLR4/MD2. Macrophages from MARCO
2/2 mice also produce markedly lower levels of pro-inflammatory cytokines in
response to infection with virulent Mtb. These observations identify the scavenger receptors as essential binding receptors
for TDM, explain the differential response to TDM of various macrophage populations, which differ in their expression of the
scavenger receptors, and identify MARCO as a novel component required for TLR signaling.
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Introduction
Mycobacterium tuberculosis (Mtb), a causative agent of human
tuberculosis, is responsible for 8 million new infections and 2
million deaths yearly. One third of the world population is
currently estimated to be infected with M. tuberculosis, although less
than 10% of those infected show clinical signs of infection [1]. This
is mainly due to the robust granulomatous response that is initiated
by the bacterium, which effectively contains the infection and
allows the host to exist in equilibrium with a subclinical infection.
The granulomatous response has been shown to be triggered by
multiple components of the mycobacterial cell wall, such as
phosphatidylinositol dimannoside, phosphatidylinositol hexaman-
noside, and trehalose 6,69-dimycolate (TDM) [2–5].
The chemical structure of TDM (also known as cord factor) was
solved in 1956 [6] and was identified as the predominant
immunogenic mycobacterial cell wall glycolipid [7]. TDM can
elicit pro-inflammatory cytokine production in vitro, and granulo-
matous responses in vivo, when administered as a monolayer or
part of an oil-water emulsion [7–10] . Although it has been known
for decades that this pro-inflammatory response is mediated
primarily by macrophages, binding or signaling receptors for
TDM on macrophages have yet to be identified. Biochemical
approaches used in our laboratory to identify TDM receptors,
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phagosome isolation from labeled macrophages, and mass
spectrometric analysis of phagocytosed TDM-coated beads after
photoactivatable cross-linking, have been unsuccessful. These
observations, as well as the finding that the stimulatory activity
of TDM requires presentation over a larger surface area, such as
emulsions, monolayers, or large diameter particles, suggests that
the TDM-receptor interaction is of low avidity and requires the
aid of co-receptors or other accessory molecules [9,10].
One class of receptors implicated in TDM recognition is the
TLRs. TLRs have not been shown to bind to TDM directly, but
bone marrow-derived macrophages (BMMW) from MyD88
2/2
mice do not produce pro-inflammatory cytokines in response to
TDM-coated polystyrene microspheres [9]. Although TLRs have
been shown to sense and signal from within the phagosome, they
are not phagocytic receptors and usually require the presence of a
co-receptor (e.g. CD14) to present their ligands [11].
Class A scavenger receptors (SR), SRA and MARCO, are a class
of phagocytic receptors that we have demonstrated mediate
recognition and presentation of TDM. SRs bind a range of ligands
of endogenous and exogenous origin with relatively low affinity.
Ligands for the SRs include proteins [12] and lipids. These lipids
can be derived from either the host (e.g. oxidized lipids) [13], or
from exogenous sources (e.g. lipopolysaccharide) [14]. Of the two
class A SRs, SRA has been clearly demonstrated to be involved in
host defense by suppressing excessive pro-inflammatory cytokine
production in mouse models of infection and septic shock [14,15].
MARCO has also been implicated in host defense against bacterial
pathogens, but it is not clear whether it is a positive or negative
regulator of pro-inflammatory cytokine production [16,17].
It has been proposed that the class A SRs may be involved in
host defense against mycobacterial infection. SRA expression is
increased after interferon-gamma (IFN-c) treatment or exposure to
M. tuberculosis, and is highly expressed on macrophages associated
with M. bovis Bacille Calmette-Gue ´rin (BCG)-induced granulomas
[14,18]. There are conflicting reports as to whether expression of
SRA increases uptake of M. tuberculosis or BCG; however, its
presence does not appear to affect the rate of replication of BCG,
despite being protective against BCG-primed endotoxic shock
[14,18]. In mouse models, MARCO expression has been shown to
be transiently up-regulated on macrophages in response to BCG
infection and to be expressed on macrophages within, and
adjacent to, BCG-containing granulomas [19]. MARCO-express-
ing macrophages in the splenic marginal zone appear to
phagocytose more BCG than neighboring macrophages that do
not express MARCO [19]. The mycobacterial ligands that
mediate this recognition have not yet been identified.
Herein, we identify that TDM recognition and signaling is
mediated, at least in part, by MARCO, TLR2, and CD14.
Although SRA and MARCO have many common ligands, our
results show that MARCO binds more TDM-coated beads than
either isoform of SRA. MARCO is required for TDM-induced
signaling via TLR2 and CD14 in a transfection system, whereas
SRAI and SRAII require co-transfection of TLRs 2 and 4, and
their accessory molecules, to permit even a minor response to
TDM stimulation. Consistent with these data, both resident
peritoneal macrophages (RPMw) and BMMw from TLR2/4
double-deficient mice (but not the individual mutants) have a
markedly reduced response to TDM. This suggests that TDM
engages TLR2 and TLR4 in a redundant fashion and that these
predominantly MyD88-dependent pathways are required for the
stimulatory effects of TDM [9]. When stimulated with TDM-
coated microspheres, macrophages from MARCO
2/2 and
MARCO
2/2 SRA
2/2 double-deficient (DKO) mice also show
reduced activation of ERK1/2 compared to wildtype mice and are
defective in subsequent pro-inflammatory cytokine production.
These macrophages also produce fewer pro-inflammatory cyto-
kines in response to infection with M. tuberculosis, indicating that
SR-mediated detection of TDM may be an important component
of the response to infection. On the basis of these data we propose
a model in which MARCO, and to a lesser extent SRA, cooperate
with TLR2 and CD14 for TDM recognition and signaling.
Results
Bone marrow-derived macrophages are less responsive
to TDM than resident peritoneal macrophages
BMMw secrete proinflammatory cytokines in response to TDM
coated onto microspheres that are too large to be phagocytosed
[9], whereas RPMw readily produce TNF-a in response to
phagocytosable TDM-coated microspheres and secrete much
higher amounts than BMMw in response to larger microspheres
(Fig. 1A). RPMw express high levels of MARCO and SRA,
whereas BMMw express high levels of SRA, but do not express
MARCO at levels detectable by immunoblot (Fig. 1B). RPMw
upregulate MARCO at the RNA and protein level in response to
TDM-coated 90 mm microspheres, however we have not observed
any significant increase in MARCO expression on BMMw by
immunoblot after as many as 72 hours of exposure to LPS or
TDM-coated 90 mm microspheres (data not shown). While there
are most likely many differences between RPMw and BMMw, the
absence of MARCO expression on BMMw may account for the
differences in the response to TDM between these two cell types.
TLR2 and TLR4 are partially redundant for TDM signaling
We have previously shown that TDM-induced cytokine
production is MyD88-dependent but had not identified which
TLRs are required (9). Herein we demonstrate that both TLRs 2
Author Summary
The causative agent of tuberculosis, Mycobacterium
tuberculosis, has a lipid-rich cell wall that contains a high
percentage of mycolic acids. These mycolic acids contrib-
ute to both the impermeable nature of the cell wall and to
the immunostimulatory properties of the bacterium.
Indeed, it has been known for over 50 years that trehalose
6,69-dimycolate (TDM/cord factor) is the major immuno-
genic lipid of M. tuberculosis, which induces potent pro-
inflammatory responses from macrophages, although the
receptor has not been identified. We have demonstrated
that the toll-like receptor (TLR) pathway is required for pro-
inflammatory cytokine production in response to TDM;
however, the TLRs alone, or in conjunction with known co-
receptors, are not sufficient to induce a response. We
demonstrate that the macrophage receptor MARCO, a
scavenger receptor, is utilized preferentially to ‘‘tether’’
TDM to the macrophage and activate the TLR2 signaling
pathway, and is used preferentially over the related SRA.
Macrophages from MARCO
2/2 mice are defective in
activation of TDM-induced signaling and subsequent
pro-inflammatory cytokine production in response to both
TDM-coated beads and virulent M. tuberculosis.B y
identifying the macrophage receptors involved in initial
recognition we can now explain variable responses to TDM
between different macrophage populations (which differ
in scavenger receptor expression), and have identified a
novel co-receptor that may be involved in lipid presenta-
tion to TLRs.
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tion. BMMw from C3H/HeJ mice (defective in TLR4 signaling)
and TLR2
2/2 mice showed no reduction in TNF-a production
(Fig. 2A&B), while macrophages from TLR2/4
2/2 mice had
greatly reduced TNF-a responses to TDM (Fig. 2C). This suggests
that TLR2 and 4 can function at least in a partially redundant
manner with respect to TDM responses.
MARCO, and to a lesser extent SRA, binds to TDM-coated
microspheres
In order to determine whether TDM-coated beads were a
ligand for MARCO, CHO-K1 cells, which do not express SRs,
were transfected with plasmids encoding either MARCO or SRA,
and non-opsonic bead binding was assessed. MARCO- and SRA-
transfected cells bound significantly more beads than mock-
transfected cells, and binding was inhibited by the SR inhibitor
dextran sulfate (DxSO4), but not chondroitin sulfate (ChSO4),
which does not inhibit the SRs (Fig. 3A). Phosphatidylglyercol
(PG) was used as a negative control lipid because we have
previously shown that it can be coated onto microspheres in a
similar manner and induces a minimal cytokine response from
macrophages. PG-coated beads did not bind cells transfected with
either MARCO or SRA to a greater extent over empty vector-
transfected cells. Furthermore, PG bead binding to cells could not
be inhibited by SR inhibitors, indicating that binding was not
MARCO- or SRA-specific (data not shown). SRA-transfected cells
bound fewer TDM-coated beads despite having higher transfec-
tion efficiency (Fig. 3B) indicating that SRA may have a lower
binding affinity for TDM-coated beads.
Expression of MARCO or SRA allows TDM-induced NF-kB
signaling in TLR-transfected HEK293 cells
HEK293 cells do not express most TLRs, except for TLRs 1, 5,
and 6 (C. Leifer, personal communication) and are therefore often
used for reconstitution assays. By co-transfecting these cells with a
luciferase reporter driven by an NF-kB promoter and various
combinations of TLRs and SRs, we determined which combina-
tions of receptors allow TDM-induced NF-kB signaling. HEK293
cells transfected with only TLR2 or TLR4, with accessory
molecules CD14 or MD2, respectively, did not respond to
TDM-coated 90 mm microspheres more than PG-coated micro-
spheres or medium alone (Fig. 4A). The addition of human
MARCO (hMARCO) to TLR2/CD14 or TLR2/CD14/TLR4/
MD2, however, allowed statistically significant (p,0.05) stimula-
tion of luciferase activity in response to TDM (Fig. 4A).
Interestingly, transfection of human SRAI (Fig. 4B) or SRAII
(data not shown) required both TLRs 2 and 4, with their respective
accessory molecules, in order for TDM-induced stimulation to be
observed. These results suggest that MARCO is required for
TDM-induced signaling via TLR2/CD14 and that SRA is less
efficient in mediating responses to TDM, requiring both TLRs 2
and 4, as well as their accessory molecules.
TDM- induced binding and signaling is independent of
the cytoplasmic region of MARCO
The scavenger receptors have been implicated in modulating
TLR signaling by a variety of TLR agonists, but it is not clear if
they alter these responses by direct involvement in the signaling
pathway. In order to determine whether the cytoplasmic region of
MARCO (which would, in theory, transduce signaling events)
could contribute to TDM-induced NF-kB activation, two
constructs of MARCO were made. The first (Myr MARCO)
lacks amino acids 1–40 but contains a putative myristoylation site;
the second (N-tail) lacks the entire cytoplasmic domain (1–49)
(Fig. 5A). After confirming that the constructs were expressed on
the surface of transfected cells (Fig. 5C), their ability to restore
TDM-induced NF-kB activation was tested. Cells transfected with
either the wild-type MARCO (hMARCO), or the two deletion
mutant constructs (Myr MARCO and N-tail MARCO), in
addition to TLR2 and CD14, retained their ability to induce
NF-kB activation (Fig. 5B). These data suggest that the
cytoplasmic region of MARCO is not required for binding or
signaling responses to TDM.
MARCO is recruited to the membrane of TDM-coated
bead phagosomes
Confocal immunofluorescence microscopy was performed to
determine whether MARCO or SRA localizes to the membrane of
phagosomes containing TDM-coated or control beads. At early
time points (5–10 minutes), MARCO recruitment to TDM bead
Figure 1. RPMw are more responsive than BMMw to TDM-coated microspheres. RPMw and BMMw were stimulated with TDM-coated
microspheres for 24 h and TNF-a was assayed by ELISA. RPMw produce substantial levels of TNF-a in response to a range of sizes of TDM-coated
microspheres. BMMw only produce significant amounts of TNF-a in response to large (90 mm diameter) TDM-coated microspheres (Fig. 1A). Bars are
representative of three independent experiments; error bars represent the standard deviation of the mean. BMMw and RPMw from 129sv/ev mice
were collected. SRA is expressed on both BMMw and RPMw whereas MARCO is only expressed on RPMw (Fig. 1B).
doi:10.1371/journal.ppat.1000474.g001
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and RPMw (Fig. 6A). Recruitment was not clearly evident in
MARCO-transfected CHO-K1 cells or in RPMw that had
phagocytosed bovine serum albumin (BSA)- or PG-coated
microspheres (Fig. 6A and C, and data not shown). SRA staining
of RPMw did not show strong co-localization with TDM- or BSA-
bead phagosomes at this early time point (Fig. 5B), and SRA-
transfected CHO-K1 cells showed no appreciable accumulation of
SRA at the phagocytic cup in response to either TDM or BSA-
coated beads (Fig. 6B and D). At later time points (15–30 minutes),
both MARCO and SRA staining occurred at the site of binding to
the TDM-, PG-, and BSA-coated microspheres (data not shown),
consistent with previous observations that the scavenger receptors
are involved in the binding and uptake of polystyrene beads [20].
From these results, we conclude that MARCO is specifically
recruited to the phagosomal membrane surrounding TDM-coated
beads, whereas SRA recruitment is non-specific.
Scavenger receptors are required for TDM-induced MAPK
activation and TNF-a production
RPMw from wildtype, MARCO
2/2, SRA
2/2, MARCO
2/2
SRA
2/2 (DKO), TLR2
2/2/TLR4
2/2 and CD14
2/2 mice were
stimulated with lipopolysaccharide (LPS), Pam3Csk4, microspheres
coated with either TDM or PG, or medium only, and lysates were
immunoblotted for phosphorylated ERK1/2. ERK1/2 was
phosphorylated in response to TDM-coated microspheres in
wild-type macrophages (Fig. 7). There was no detectable decrease
in the TDM response by SRA
2/2 macrophages (data not shown);
however, MARCO
2/2 macrophages had a reduced response to
TDM, and ERK1/2 phosphorylation was further reduced in
macrophages from DKO mice (Fig. 7). The levels of ERK1/2
phosphorylation in response to LPS and Pam3Csk4 were similar
between wildtype and SR-deficient macrophages indicating that
the SR knockouts do not have a global defect in their ability to
phosphorylate ERK1/2 in response to TLR agonists but are
specifically defective in the TDM response (Fig. 7). Equivalent
levels of ERK1/2 activation by LPS in CD14-deficient RPMw
may be due to soluble CD14 provided by fetal calf serum in the
medium and the high dose of LPS used [21].
Because the SRs are required for TDM-induced ERK1/2
activation (Fig. 6), we hypothesized that SR-deficient macrophages
might also be defective in downstream pro-inflammatory cytokine
production. RPMw from wildtype, MARCO
2/2, SRA
2/2 or
DKO mice were stimulated with 3 mm diameter TDM-coated
beads for 24 hours. Both the MARCO
2/2 and SRA
2/2
macrophages had a statistically significant reduction in TNF-a
production (P,0.05). TNF-a production from DKO macrophages
was completely abrogated (P,0.025) (Fig. 8C). This is not due to
decreased levels of TLR2 (Fig. 8A) or TLR4 (Fig. 8B) expression
on the SR-deficient macrophages, as these are both expressed at
equivalent levels between wildtype and SR
2/2 RPMW.
The mouse macrophage cell line, RAW264.7, is similar to
BMMw in expressing high levels of SRA (data not shown) but
lacking MARCO at both the protein (Fig. 9B) and RNA levels
(data not shown), and in producing lower levels of cytokines in
response to TDM as compared to RPMw (Fig. 9A). We predicted
that transfection of RAW264.7 with MARCO could elevate
responsiveness to TDM. Stable cell lines expressing either human
MARCO (hMARCO-RAW) or an empty vector (vector) were
created and stimulated with TDM- or PG-coated microspheres for
24 hours, after which the levels of TNF-a in the medium were
assessed by ELISA. Only the hMARCO-expressing cells produced
TNF-a in response to the TDM-coated microspheres (P,0.05)
(Fig. 9A). This result further supports the important role of
MARCO in TDM-induced cytokine production.
MARCO-deficient macrophages do not mount an
efficient inflammatory response to M. tuberculosis
TDM is an essential virulence factor for M. tuberculosis
pathogenesis and thus we hypothesized that pro-inflammatory
cytokine production resulting from M. tuberculosis infection would
also be impaired in MARCO-deficient macrophages. RPMw were
infected with an MOI of 5 for 24 hours and cytokine production in
the supernatants was assessed by ELISA. Consistent with our
hypothesis, MARCO
2/2 and DKO macrophages produced
Figure 2. TDM-induced cytokine expression requires either
TLR2 or TLR4. BMMw from mice defective in TLR4 signaling (A) or
TLR2 signaling (B) do not have reduced responses to 90 mm TDM-
coated beads, however, TLR2/4
2/2 mice (C) have markedly reduced
production of TNF-a in response to TDM, indicating that TLR2 and 4 are
redundant for TDM responsiveness. Bars are the mean of triplicate
experiments, error bars represent standard deviation of the mean. **
indicates P,0.01, as determined by student’s t test.
doi:10.1371/journal.ppat.1000474.g002
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phages (Fig. 10).
Discussion
The pathogenesis and establishment of M. tuberculosis infection
requires phagocytosis of the bacterium by macrophages and
initiation of the pro-inflammatory response. These two events are
at least partially independent. Phagocytosis is mediated by a
number of receptors including the mannose receptor and DC-
SIGN which recognize mannose-capped lipoarabinomannan
(ManLAM) [22,23], and complement receptor which mediates
the phagocytosis of both opsonized and non-opsonized bacteria
[24]. The initiation of a pro-inflammatory response appears to be
mediated primarily via TLRs [25] and possibly other signaling
receptors such as dectin-1 [26]. Of the mycobacterial cell wall
lipids that initiate a TLR-mediated inflammatory response, TDM
appears to be one of the more potent [9].
Although we have demonstrated that the macrophage response
to TDM is partially TLR2/4-dependent (Fig. 2), our initial
attempts to reconstitute NF-kB signaling in a TLR2/4 stably-
transfected cell line were not successful. It seemed likely that this
was due to the requirement of an additional co-receptor, because
many TLR ligands, and especially lipid-based ligands, require
presentation via a co-receptor. The co-receptor CD14 has been
implicated in facilitating TLR1/2-mediated responses to bacterial
lipopeptides by enhancing the physical proximity of the ligand to
the TLR1/2 heterodimers, without binding directly to the
receptor complex [25,27,28]. However, CD14 expression in
conjunction with TLR2 or TLR4 did not restore responsiveness
to TDM (Fig. 4) suggesting that CD14 was not the only co-
receptor for TDM. Because MARCO and SRA bind to TDM-
coated beads (Fig. 3A), we hypothesized that they might be the
additional co-receptors required for TLR2 signaling. Both
MARCO and CD14 in conjunction with a TLR2 homo- or
heterodimer appear to be required to initiate TDM signaling, and
MARCO appears to be preferred over the closely related SRA
(Fig. 4A and B, Fig. 7). We therefore propose that the scavenger
receptors function as co-receptors that, in conjunction with CD14,
present TDM to TLR2. Further work is warranted to determine
whether TDM signaling requires an additional receptor such as
TLR1 or TLR6. The structure of TDM, however, does not
include di-acylated lipids that signal via TLR2/6 heterodimers or
tri-acylated lipids that signal via TLR1/2 heterodimers [29].
SRA has been demonstrated to modulate TLR signaling [30,31]
and macrophages from both SRA- and MARCO-deficient mice
Figure 4. Expression of MARCO restores TLR2-mediated signaling in response to TDM-coated microspheres. HEK293 cells were
transfected with plasmids encoding various TLRs (TLR2 or TLR4), accessory molecules (MD2 or CD14), or scavenger receptors (SRAI SRAII, hMARCO),
and NF-kB-luciferase and b-galactosidase reporter plasmids. Transfected cells were stimulated with 90 mm diameter TDM- or PG-coated beads, and
NF-kB activity (relative light units) was measured. (A) NF-kB activity cannot be induced in transfected cells without, at minimum, hMARCO, TLR2, and
CD14. (B) Only a very slight increase in NF-kB signaling is observed when either isoform of SRA is present in addition to TLR2/CD14, TLR4/MD2. PG-
coated microspheres do not induce significantly greater NF-kB activation over medium only controls (A and B). Bars are representative of at least 3
independent experiments6standard deviation from the mean. Statistically significant increases (P,0.05) are marked with an asterisk.
doi:10.1371/journal.ppat.1000474.g004
Figure 3. MARCO-transfected cells bind TDM-coated beads. (A) CHO-K1 cells were transfected with plasmids containing human MARCO
(hMARCO), mouse MARCO (mMARCO), or two isoforms of human SRA (hSRAI or hSRAII). Binding was assessed by incubating cells on ice, with or
without the scavenger receptor inhibitor dextran sulphate (DxSO4) or the non-inhibitor chondroitin sulphate (ChSO4)), and then adding TDM-coated
beads. Cells were washed, fixed, and the numbers of beads in at least five fields of view were counted. Bars represent the average of three
independent experiments; error bars represent the standard error of the mean. Asterisks indicate P,0.05. (B) Immunofluorescence of transfected
CHO-K1 cells. Cells were transfected with hMARCO, mMARCO, hSRAI or hSRAII and stained as per the Materials and Methods. SRA expression was
consistently higher than MARCO expression. One representative experiment of at least three shown.
doi:10.1371/journal.ppat.1000474.g003
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It is not entirely clear, however, if the SRs are able to signal
directly or if they have an indirect function in the signaling
pathway, for example, by phagocytosing and clearing TLR
agonists. In order to test whether MARCO might be signaling
directly, we created mutants that lacked the cytoplasmic domain,
and thus any putative signaling motifs, of MARCO. The
cytoplasmic region of MARCO has not been experimentally
demonstrated to have any residues that are essential for cell
signaling and indeed, apart from the putative myristoylation site at
residues 41–46, does not contain any potential signaling motifs
identifiable by scanning various protein motif databases (D.M.E.-
Bowdish, unpublished results). After confirming that these
constructs were expressed on the surface of transfected CHO-K1
and HEK293 cells, we determined that they could indeed bind to
TDM-coated beads and were in fact able to reconstitute TDM-
induced NF-kB signaling (Fig. 4). Our receptor-ligand interaction
assay results, however, show that MARCO alone is not sufficient
for TDM binding, and that other receptors present on the surface
of RPMw must cooperate with MARCO for effective binding to
occur (Fig. S1, Text S1). Signaling induced by TDM may be
independent of the phagocytic function of the scavenger receptors,
as macrophages from the SRA
2/2, MARCO
2/2 and DKO mice
did not have any detectable defect in phagocytosis of TDM-coated
beads (data not shown). These data are consistent with a role for
MARCO as a ‘‘tethering’’ receptor for TDM, perhaps extracting
Figure 5. The cytoplasmic region of MARCO is not required for TDM-induced signaling or binding. (A) Constructs of MARCO were
cloned. The full length (wildtype) version of MARCO has a 49 amino acid cytoplasmic (NH2) tail. Two constructs based on this sequence were made.
The first lacks amino acids 1–40, but contains the putative myristoylation site, which is marked in bold (Myr MARCO). The second lacks the entire 49
amino acid cytoplasmic domain (N-tail MARCO). (B) HEK293 cells were transfected with plasmids encoding TLR2, CD14, and the MARCO constructs in
addition to the NF-kB-luciferase and b-galactosidase reporter plasmids. Transfected cells were stimulated with 90 mm diameter TDM- or PG-coated
beads and NF-kB activity (relative light units) was measured. The presence of full-length or constructs missing all or part of the cytoplasmic tail were
sufficient to allow TDM-induced signaling. (C) MARCO constructs are expressed on the surface of HEK293T cells. Although Myr MARCO and N-tail
MARCO are expressed at slightly lower levels than hMARCO, they are detectable on the surface of the HEK293T cells as detected by FACS. Bars
represent the mean6standard deviation from the mean.
doi:10.1371/journal.ppat.1000474.g005
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PLoS Pathogens | www.plospathogens.org 7 June 2009 | Volume 5 | Issue 6 | e1000474individual lipids and presenting them to the CD14/TLR2
complex (Fig. 11), but MARCO itself appears to lack a direct
signaling function.
Our observation that MARCO is the preferred receptor for
TDM may explain why some macrophage populations respond
robustly to TDM, while others do not. For example, RPMw, which
express high levels of MARCO, respond strongly to TDM, whereas
BMMw and RAW264.7 cells, which express SRA but not
MARCO, produce a minimal amount of pro-inflammatory
cytokines in response to TDM. We therefore propose that MARCO
is thepreferred receptorforTDM, althoughthelessavid interaction
between SRA and TDM can also facilitate signaling through TLRs.
This hypothesis is consistent with the work of Ozeki et al. in which it
was shown that SRA can bind to TDM in vitro and plays a role in
suppressing TNF-a production by alveolar macrophages or Kupffer
cells in response to TDM-coated wells [32].
Because TDM is highly immunogenic, it is being studied as an
adjuvant that boosts both humoral and cellular immune responses
[33,34], is a novel candidate for vaccine development [35], and is
used to mimic the pathogenesis of M. tuberculosis infection [36].
Indeed, our observation that MARCO-deficient macrophages are
defective in pro-inflammatory cytokine production in response to
either TDM or virulent M. tuberculosis is consistent with our
hypothesis that TDM is the major immunogenic lipid associated
with pro-inflammatory responses. It is likely that TDM is not the
only ligand for the scavenger receptors on M. tuberculosis and
further study is warranted to elucidate what these interactions
might be; however, our data suggests that this interaction is a
major component of the macrophage response to infection. We
propose that TDM is a novel SR ligand that binds to MARCO
with a higher affinity than SRA and that the TDM-induced pro-
inflammatory response is mediated in large part via SR/TLR2/
CD14 receptors. . These observations may explain why some
macrophage populations respond more strongly than others to
TDM and thus will provide novel insight into the role of the
scavenger receptors in the pathogenesis of tuberculosis.
Materials and Methods
Animals
C57BL/6, SRA
2/2, MARCO
2/2, MARCO
2/2 SRA
2/2
(DKO), CD14
2/2, C3H/HeN, C3H/HeJ and 129sv/ev mice
were bred and housed at the University of Oxford, Cornell
University, or University of Georgia. All SR knockout mice were
created on the C57BL/6 background strain [15,17,37]. The
SRA
2/2 and DKO mice are deficient in SRAI and SRAII. Unless
otherwise stated, C57BL/6 mice were used as wild-type and were
purchased from either Taconic or Harlan. TLR2/4 double-
deficient mice were created by Shizuo Akira (Osaka University),
generously supplied by Lynn Hajjar (University of Washington),
Figure 6. TDM beads induce clustering of MARCO at the phagosomal membrane. RPMw were stimulated with TDM-coated or negative
control (BSA) beads for 5 minutes. (A) Endogenous MARCO is recruited to the phagosomal membrane in response to TDM, but not BSA. SRA staining
is apparent at the surface of RPMw but does not clearly co-localize with the phagosomal membrane surrounding TDM-coated or BSA-coated beads
(B). CHO-K1 cells that are transiently transfected with human MARCO stain for concentrated expression around TDM beads (as indicated by arrows)
but not BSA-coated beads (C). Transfected human SRA is not clearly recruited to the TDM bead phagosomal membrane to the same extent as MARCO
and displays similar diffuse staining in response to TDM-coated beads as BSA-coated beads (D).
doi:10.1371/journal.ppat.1000474.g006
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Facility. All mice were housed in specific pathogen-free conditions
and experiments were designed to use age- and sex-matched mice,
between 5 weeks and 3 months of age. All animal experiments
were approved by the ethics board of the university at which the
experiments were performed (i.e. University of Oxford or Cornell
University).
Cell culture
CHO-K1 cell line (ATCC#CCL-61) was maintained in Ham’s
F12K medium (Gibco) supplemented with 10% heat-inactivated
fetal calf serum (HI-FCS, Hyclone), 2 mM L-glutamine, 1.5 g/L
sodium bicarbonate, 100 U/ml penicillin, and 100 mg/ml strep-
tomycin (Gibco). CHO-K1 cells were transfected using Lipofecta-
mine as per the manufacturer’s instructions (Invitrogen). The
HEK293 cell line (ATCC# CRL-1573) was provided by Cynthia
Leifer, cultured in Dulbecco’s Modified Eagle Medium (DMEM;
Gibco) supplemented with 10% HI-FCS, 2 mM L-glutamine,
1 mM sodium pyruvate, 10 mM HEPES (Gibco), 100 U/ml
penicillin, and 100 mg/ml streptomycin. Transfected RAW 264.7
cells were maintained in RPMI, 10% HI-FCS, 2 mM L-
glutamine, and 100 mg/ml ascorbic acid (Sigma). BMMw were
cultured as described previously [9] and maintained in DMEM
supplemented with 20% L-929 cell-conditioned media, 10% HI-
FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U/ml
penicillin, and 100 mg/ml streptomycin. RPMw were obtained by
lavaging the peritoneal cavity with 10 ml cold phosphate-buffered
saline (PBS), re-suspending the peritoneal cells in complete growth
medium (DMEM supplemented with 10% HI-FCS, 2 mM L-
glutamine, 1 mM sodium pyruvate, 100 U/ml penicillin, and
100 mg/ml streptomycin) and allowing the macrophages to adhere
to Petri dishes overnight. Non-adherent cells were then rinsed off
before RPMw were used for experiments. All media components
were routinely tested for endotoxin by Limulus Amoebocyte Assay
(Cambrex). All cells were maintained at 37uC and 5% CO2..
Antibodies and other reagents
The monoclonal anti-MARCO clones ED31 (anti-mouse
MARCO) and PLK-1 (anti-human MARCO), and anti-SRA
clone 2F8 were grown and maintained at the Gordon laboratory.
Polyclonal anti-hMARCO antibodies were a generous gift from
Dr. Timo Pikkarainen. Anti- mouse TLR2 and TLR4 antibodies
were purchased from eBioscience. Rabbit antibodies for phos-
phorylated and total ERK1/2 (Cell Signaling Technologies) were
used according to manufacturer’s protocols. Peroxidase-conjugat-
ed goat anti-mouse or anti-rabbit antibodies (Jackson Labs) were
used at 1:200 for immunoblotting. AlexaFluor 488 or 594 goat
anti-mouse IgG antibodies (Molecular Probes) were used as
secondary antibodies for immunofluorescence.
TDM from M. tuberculosis H37Rv strain and bovine-derived PG
(Sigma-Aldrich) were resuspended in chloroform/methanol (2:1
v/v) at 10 mg/ml and stored at 220uC under nitrogen. Sterile
3 mm and 90 mm diameter polystyrene microspheres or 2.5 mm
fluorescent polystyrene microspheres (Polysciences) were coated
with TDM or PG as described previously [9]. Coated micro-
spheres were washed and re-suspended in endotoxin-free PBS
(Invitrogen) at 2% solids. It should be noted that the manufac-
turing protocol for these microspheres was changed by Poly-
sciences in 2007, resulting in less efficient coating of the
polystyrene particles by lipids and therefore reduced immunosti-
mulatory ability. Original results could be reproduced using
80 mm diameter polystyrene microspheres from Duke Scientific.
Plasmids and constructs
Human TLR4, MD2, TLR2, and CD14 plasmids were
generously provided by Dr. Cynthia Leifer (Cornell University).
Figure 7. TDM-induced MAPK activation requires scavenger receptors and CD14. TDM induces phosphorylation of ERK1/2 in RPMw from
wildtype mice. Phosphorylation of ERK1/2 is markedly reduced in macrophages from MARCO
2/2 mice and almost completely abrogated in
macrophages from the DKO. A reduction of TDM-induced phosphorylation also occurs in CD14
2/2 macrophages. Activation of ERK1/2 in response to
LPS and Pam3Csk4 was normal in all knockouts. Blots were stripped and re-probed with antibodies for total ERK1/2 to control for loading differences.
One representative experiment of two shown.
doi:10.1371/journal.ppat.1000474.g007
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Prep columns (Qiagen). The plasmids containing human
MARCO (hMARCO), mouse MARCO (mMARCO), human
SRAI and SRAII have been previously described [38,39].
Constructs of human MARCO that were missing the cytoplasmic
tail (N-tail hMARCO or Myr hMARCO) were created by
designing primers that amplified the transmembrane region of
hMARCO and contained restriction enzyme sites. After amplifi-
cation and restriction digest, the amplified fragment was sub-
cloned into pcDNA3.1 (Invitrogen).
Stable cell lines expressing either hMARCO or the empty
vector (pcDNA3) were created in RAW264.7 cells by transfecting
the cells per the manufacturer’s directions (GeneJuice, EMDbios-
ciences) and selecting under G418. Surviving cells were tested for
MARCO expression by flow cytometry and immunoblot, and
were cultured in 1 mg/ml G418 until use.
Microsphere binding assay
CHO-K1 cells were transfected with plasmids encoding either
MARCO or SRA as described above. Medium was removed and
replaced with Opti-MEM (Invitrogen). Non-opsonic bead binding
was assessed by incubating the cells on ice for 30 min with or
without inhibitors, then adding TDM or PG-coated, fluorescent,
3 mm diameter microspheres. After 30 min on ice, the cells were
washed, fixed, and bead binding was assessed by microscopy.
Dextran sulfate (DxSO4) or chondroitin sulfate (ChSO4) were used
at concentrations of 100 mg/ml.
Luciferase assay
HEK293 cells were seeded at 5610
5 cells per well in 2 ml of
medium per well in a 6 well plate overnight. HEK293 cells were
transfected according to manufacturer’s protocol using TransIT
transfection reagent (Mirus) with 144 ng each of NF-kB-luciferase
Figure 8. SR knockout mice are defective in responses to TDM. Levels of TLR2 (A) and TLR4 (B) are equivalent between wildtype and SR
knockout mice. RPMw from MARCO
2/2 and SRA
2/2 mice demonstrate reduced TNF-a production in response to 3 mM TDM coated beads while
macrophages from a DKO are completely abrogated (C). Data from figure C were normalized for cell number using crystal violet staining (see
Materials and Methods for details). Bars represent the average of at least three independent experiments; error bars represent the standard error of
the mean. Asterisks indicated a significant difference from the wildtype as measured by a student t test. *=P,0.05, **=P,0.01.
doi:10.1371/journal.ppat.1000474.g008
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CD14, or TLR4, 90 ng MD2, and 300 ng MARCO or SRAI/II
per well depending on the experiment. Total DNA was brought to
2 mg using empty vector (pcDNA3.1). Transfected cells were
incubated for 24 hours before trypsinization and reseeding in 96
well plates (one row of a 96 well plate from each well of the 6 well
plate) in 100 ml media/well. After another 24 hours, cells were
stimulated with either 1.25610
3 TDM- or PG-coated 90 mm
polystyrene microspheres per well, or positive control ligands
1 mg/ml Pam3Csk4 (Calbiochem) or 100 ng/ml lipopolysaccha-
ride (Sigma) as positive controls for TLR2 and TLR4, respectively.
Only data from experiments, in which positive responses to LPS
and Pam3Csk4 were consistent between relevant transfectants,
were used in order to assure functional TLR4 and TLR2
complexes were expressed at equivalent levels. In addition, only
experiments in which equivalent levels of MARCO and SRA were
expressed, as determined by FACS, were used. After 18 hours,
transfected cells were lysed using Reporter Lysis Buffer (Promega)
and lysates were analyzed for luciferase (Promega) and b-
galactosidase (Tropix) activity using a Veritas luminometer
(Turner Biosystems). NF-kB activity (relative light units) was
measured by dividing luciferase activity by b-galactosidase activity,
and then fold activity was calculated by dividing TDM and PG
results by medium only results. Statistical significance was
determined using Student’s t test.
Immunofluorescence and FACS
RPMw, or CHO-K1 cells transfected with hMARCO for
24 hours as described above, were seeded onto cover slips at
1610
5 cells per well in 500 ml of media. Washed, 3 mm diameter,
carboxylated silica beads (Kisker Biotech) were re-suspended in
Figure 9. The presence of hMARCO restores TDM responses to a non-responsive cell line. RAW264.7 cells that stably expresses human
MARCO (hMARCO- RAW) and a control cell line expressing the empty vector (vector-RAW) were created (B). After 24 hours of stimulation with 3 mm
diameter TDM-coated microspheres, the vector-RAW cell line did not produce TNF-a, however there was a significantly increased level of TNF-a
production in the hMARCO expressing cell line (A, P,0.025). One representative experiment of 3 shown. Bars represent the mean and error bars
represent the standard deviation of the mean.
doi:10.1371/journal.ppat.1000474.g009
Figure 10. Macrophages from MARCO
2/2 and DKO mice have
significantly reduced cytokine production in response to M.
tuberculosis. RPMw were infected with virulent M. tuberculosis strain
H37Rv for 24 hours. Cytokine production was assessed by ELISA.
Macrophages from MARCO
2/2 and DKO mice were defective in TNF-a,
IL-6 and IL-1b. One representative experiment of 3 shown. Bars
represent the mean and error bars represent the standard deviation
of the mean. Asterisks indicate P,0.05(*) or P,0.005(**) when
compared to wildtype macrophages.
doi:10.1371/journal.ppat.1000474.g010
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incubated with agitation for 15 minutes. Excess cyanimide was
removed by washing twice in 0.1 M sodium borate pH 8.0
(Sigma-Aldrich). The beads were then cross linked to defatted BSA
in a 10 mg/ml solution for 2 hours with agitation, followed by
labeling with 2 mg/ml carboxyfluoresceinthiosemicarbazide (Mo-
lecular Probes) for 30 minutes with agitation. After washing with
PBS, the beads were then passively coated with TDM as described
above. Beads were added to cells at a ratio of 5:1, maintained at
room temperature for five minutes, then incubated at 37uC for five
minutes, before rinsing with PBS and fixing in 4% paraformal-
dehyde in PBS. Cells were blocked overnight at 4uC in staining
buffer (SB; 1% BSA, 1% heat-inactivated goat serum, 0.25%
saponin in PBS), then incubated with 10 mg/ml primary antibody
in SB for 1 hour at room temperature, washed three times with
PBS, and then incubated with secondary goat anti-mouse antibody
also for 1 hour at room temperature. Cover slips were rinsed three
times with PBS, then quickly in double-distilled water before
mounting using Prolong Gold Antifade medium (Molecular
Probes). Confocal images were taken using an Olympus Fluoview
500 confocal laser scanning imaging system equipped with argon,
krypton, and He-Ne lasers on an Olympus IX70 inverted
microscope with a PLAPO 606 objective (Olympus America,
Inc.). Confocal images were processed using Adobe Photoshop 6.0
(Adobe Systems, Inc.,).
For FACS analysis, cells were transfected with plasmids as
described above and stained with either the appropriate MARCO-
or SRA-specific antibodies or corresponding isotype controls as
per standard protocols.
Immunoblotting
To assess SR expression, BMMw, RPMw, and RAW264.7 cells
were seeded in 6 well plates overnight in the appropriate media
(discussed above). The cells were lysed in RIPA buffer [50 mM
Tris-HCl (pH 7.4), NP-40 1%, sodium deoxycholate 0.25%, NaCl
150 mM, EDTA 1 mM, PMSF 1 mM, and protease inhibitors
(Roche)], then assessed for protein concentration by Bradford
Assay (Bio-Rad). Equivalent amounts of protein per sample were
boiled in 26 non-reducing sample buffer for five minutes,
centrifuged, and separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE). Samples were transferred
to nitrocellulose membranes, and then blocked in 5% nonfat dry
milk in 0.1% Tween-20 in PBS (PBST) overnight with gentle
rocking. Both primary and secondary antibodies were diluted in
blocking buffer, and applied to membranes for one hour at room
temperature with gentle rocking, and with three 5 minute washes
with PBST between incubations.
For MAPK immunoblots, RPMw were seeded at approximately
5610
5 cells per well in a 24 well plate in R10 medium and allowed
to adhere overnight. After 16 hours, the cells were washed once
with PBS and the medium was replaced with 450 ml of warm R10.
RPMw were stimulated with either 100 ng/ml of LPS, 1 mg/ml
Pam3Csk4, or 1.9610
3 TDM- or PG-coated 90 mm diameter
beads, or PBS as a vehicle control. After stimulation, the medium
Figure 11. MARCO is a component of the TDM signaling complex. MARCO functions as a tethering receptor that functions in conjunction
with CD14 and TLR2. Presumably CD14 is involved in extracting or presenting the lipid to the TLRs. MARCO is used preferentially over SRA, possibly
because it has a higher binding affinity for TDM. Phagocytosis occurs concurrently but is not necessarily mediated by the class A scavenger receptors.
doi:10.1371/journal.ppat.1000474.g011
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reducing sample buffer. Lysates were placed on ice, syringed to
shred DNA, then boiled for five minutes at 100uC, centrifuged and
stored at 220uC until use. Equal volumes of sample were loaded
per lane for SDS-PAGE. Proteins were transferred to nitrocellu-
lose membranes and blocked with 5% nonfat dry milk in TBST
[10 mM Tris–HCl (pH 8), 150 mM NaCl, 0.1% Tween-20]. The
filters were then incubated overnight at 4uC with anti-ERK1/2-P
antibodies (Cell Signaling Technology). Anti-total ERK1/2
antibody was used to show equivalent lane loading. Immunore-
active bands were detected using horseradish peroxidase-conju-
gated goat anti-rabbit IgG antibodies (Jackson Immunoresearch)
and chemiluminescence (Pierce).
Cytokine assay
BMMw or RPMw were counted and seeded at approximately
1610
5 cells/well in 100 ml media/well in 96 well plates, or 4610
5
cells/well in 500 ml media/well in 24 well plates. RAW264.7
constructs were counted and seeded at approximately 1610
4 cells/
well in 96 well plates. RPMw were washed once with PBS to
remove non-adherent cells and the media replaced with Opti-
MEM. Macrophages were stimulated with either TDM or PG-
coated microspheres, with dose normalization for bead surface
area (total bead surface area of 5610
7 mm
2/well), 100 ng/ml of
LPS (E. coli, Sigma-Aldrich), or 100 ng/ml Pam3Csk4 (Calbio-
chem); PBS was added as a vehicle control. After 24 h, the media
were collected and the concentration of TNF-a was determined by
ELISA as per the manufacturer’s directions (BD Bioscience or
eBioscience). In experiments comparing RPMw from different
mouse genotypes, cells were stained with crystal violet to
normalize for cell numbers. The crystal violet was solubilized
with 1% SDS and the resulting supernatant was read on a plate
reader (OD 550 nm). TNF-a release is expressed as pg/ml/
OD550 to normalize for cell numbers.
In vitro infection of RPMw
RPMw were collected from MARCO
2/2, SRA
2/2, and DKO
mice as described above and seeded in equivalent numbers in 24
well plates, depending on the genotype with the lowest yield
(approximately 1610
5 cells per well). Mid-log phase cultures of
Mtb H37Rv strain were washed then added to the cells at an MOI
of 5 in 250 ml of medium. After 24 hours the medium was filtered
and analyzed for cytokines by ELISA.
Statistical analysis
Differences between the means of experimental groups were
analyzed using Student’s t test. Differences were considered
significant when P#0.05.
Supporting Information
Figure S1 TDM requires other receptors in order to pull down
MARCO. Radiolabelled hMARCO was added to TDM cova-
lently-linked to Carbolink (lane 1), fucoidan-Carbolink (lane 2), or
Carbolink only (lane 3). The positive control shows the radioactive
signal of 1 ml of the original radiolabelled hMARCO mixture.
Only fucoidan-Carbolink pulls down hMARCO under these
conditions. When RPMw lysates are also added to TDM-
Carbolink (lane 4) or Carbolink only (lane 5) pulldowns, both
pull down small amounts of hMARCO, with slightly more bound
to TDM. Lanes 4 and 5 were adjusted for greater contrast using
ImageQuant software (Molecular Dynamics).
Found at: doi:10.1371/journal.ppat.1000474.s001 (1.44 MB TIF)
Text S1 Supplementary materials and methods.
Found at: doi:10.1371/journal.ppat.1000474.s002 (0.03 MB
DOC)
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